Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: What are the best practices for undertaking epidemiologic and phenotypic studies in polycystic ovary syndrome (PCOS)? SUMMARY ANSWER: Best practices for the undertaking of epidemiologic and phenotypic studies in PCOS are outlined. WHAT IS KNOWN ALREADY: Currently methodologies used for studies of PCOS epidemiology and phenotypes vary widely, and the comparability of studies is low, reducing the ability to harmonize studies. STUDY DESIGN, SIZE, DURATION: The Androgen Excess and PCOS (AE-PCOS) Society established a Task Force to draft a research resource for epidemiologic and phenotypic studies in PCOS, with the aim of providing guidelines on study design and execution, insights into the limitations and alternatives and protocols to be used, taking into consideration a global perspective. PARTICIPANTS/MATERIALS, SETTING, METHODS: A targeted review of the literature was carried out as necessary. MAIN RESULTS AND THE ROLE OF CHANCE: High level recommendations include the following: (i) Before initiating the study, a number of critical factors should be addressed including selecting the population and diagnostic criteria (which should ideally align with the recommendations of the International Guidelines), the type of observational study to be undertaken and the primary and secondary endpoint(s) of the study.(ii) To assess the ‘natural’ or true phenotype and epidemiology of PCOS, the least medically biased, broadest and most generalizable population, and the broadest definition of PCOS, should be used.(iii) Four PCOS phenotypes (Phenotypes A through D), based on the presence or absence of three general features (oligo-anovulation, hyperandrogenism and polycystic ovarian morphology), should be ascertained.(iv) In epidemiologic and phenotypic studies, the detection of PCOS rests on the accuracy and sensitivity of the methods used for assessing the individual features of the disorder, and how ‘normal’ is defined.(v) Although an assessment algorithm that minimizes the use of certain measures (e.g. androgen levels and/or ovarian ultrasonography) can be devised, when possible it is preferable to uniformly assess all subjects for all parameters of interest. (vi) The inclusion of subjects in epidemiologic studies who do not appear to have PCOS (i.e. ‘non-PCOS’) will provide the necessary cohort to establish population-specific normative ranges for the various features of PCOS. (vii) Epidemiologic studies of PCOS in unselected populations will yield relatively limited numbers of PCOS subjects available for genetic study; alternatively, large population-based epidemiologic studies of PCOS will potentially generate large numbers of unaffected individuals that may serve as genetic controls. (viii) Epidemiologic studies of PCOS will benefit from a clear governance structure and should begin by informing, educating and engaging both the formal and informal leaders of the populations targeted for study. (ix) In designing their study investigators should, in advance, establish statistical power and recognize, manage and account for inherent biases. (x) Subjects suspected of having PCOS but who do not/cannot complete their evaluation (i.e. have ‘possible PCOS’) can be included by imputation, assigning them a ‘diagnostic weight’ based on those subjects of similar clinical phenotype that have completed the study. (xi) In obtaining, storing and retrieving subject data, subjects should be assessed consecutively using a uniform data collection form; providing as complete and in depth data as possible. (xii) Maintenance of both paper and electronic medical records should focus on ensuring data quality, accuracy and institutional ethical compliance, and familiarity with country-dependent laws, including biobanking-specific laws, tissue laws and research laws. (xiii) In obtaining and biobanking study samples, these should be ideally collected at the time of the first assessment. (xiv) Access to stored data sets should ideally be granted to other bona fide researchers conducting research in the public interest. (xv) SOPs detailing the exact method of each of the activities for handling the data and the samples are necessary to ensure that all methods are performed uniformly. (xvi) Epidemiologic studies of PCOS must be resourced adequately. LIMITATIONS, REASONS FOR CAUTION: As with all reports involving expert interpretation of experiential and published data, inherent individual biases are possible. This risk is minimized in the present study by including experts from varying fields of study, aligning with recent international evidence-based guidelines and obtaining consensus approval of the recommendations from the Task Force and the board of the AE-PCOS. WIDER IMPLICATIONS OF THE FINDINGS: These guidelines should encourage investigators worldwide to undertake much needed epidemiologic studies of PCOS, increasing the validity, integrity and comparability of the data. STUDY FUNDING/COMPETING INTEREST(S): The study received no funding. R.A. serves as consultant for Medtronic, Spruce Biosciences and Ansh Labs; has received research funding from Ferring Pharmaceuticals; and is on the advisory board of Martin Imaging; R.L. has received research funding from MSD Pharmaceuticals; J.L. has received fees and/or grant support from the Dutch Heart Association, The Netherlands Organisation for Health Research and Development (ZonMw), Ferring Pharmaceuticals, Danone, Euroscreen/Ogeda and Titus Health Care; H.T. receives grant funding from the National Health and Medical Research Council; K.K., L.M.-P., S.S.M. and B.O.Y. have no potential conflicts of interest. TRIAL REGISTRATION NUMBER: N/A
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712
Self-citationAzziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citationMarch, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey256 · Cited by 1,593
Self-citationBozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016) · Human Reproduction · doi:10.1093/humrep/dew218 · Cited by 1,526
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Self-citationCriteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358
Self-citationAsunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Research works printed but not linked: 2
- Bonita, 2006, Basic Epidemiology
- NIH, 2012, December 3–5, 2012-EXECUTIVE SUMMARY (Final Report)
Cited by
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00511-3 · Cited by 495
“Large data sets and epidemiological studies are central to understanding the features and natural history of PCOS 285 .”
Self-citationAl Wattar, B. H., Fisher, M., Bevington, L., Talaulikar, V., Davies, M., Conway, G., & Yasmin, E. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab232 · Cited by 123
Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women
Ganie, M. A., Chowdhury, S., Malhotra, N., Sahay, R. K., Bhattacharya, P. K., Agrawal, S., Jabbar, P. K., Suri, V., Rozati, R., Sreenivas, V., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.40583 · Cited by 105
Chronic conditions in women: the development of a National Institutes of health framework
Temkin, S. M., Barr, E., Moore, H. M., Caviston, J. P., Regensteiner, J. G., & Clayton, J. A. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02319-x · Cited by 98
Advances in the study of the correlation between insulin resistance and infertility
Lei, R., Chen, S., & Li, W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1288326 · Cited by 97
Jia, L., Feng, J., Li, J., Liu, F.-Y., Xie, L., Luo, S.-J., & Han, F. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5555315 · Cited by 56
Amiri, M., Hatoum, S., Buyalos, R. P., Sheidaei, A., & Azziz, R. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae917 · Cited by 54
Self-citationVine, D., Ghosh, M., Wang, T., & Bakal, J. (2024) · CJC Open · doi:10.1016/j.cjco.2023.12.010 · Cited by 53
Teede, H. J., Gibson, M., Laven, J. S. E., Dokras, A., Moran, L., Piltonin, T., Costello, M., Mousa, A., Joham, A. E., Tay, C. T., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102927 · Cited by 52
Self-citationButler, A. E., Ramachandran, V., Sathyapalan, T., David, R. M., Gooderham, N. J., Benurwar, M., Dargham, S. R., Hayat, S., Najafi-Shoushtari, S. H., & Atkin, S. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00206 · Cited by 46
Amiri, M., Hatoum, S., Hopkins, D., Buyalos, R. P., Ezeh, U. I., Pace, L. A., Bril, F., Sheidaei, A., & Azziz, R. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae488 · Cited by 45
Self-citationBayona, A., Martínez-Vaello, V., Zamora, J., Nattero-Chávez, L., Luque-Ramírez, M., & Escobar-Morreale, H. F. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac011 · Cited by 44
Lorincz, C., Börzsei, D., Hoffmann, A., Varga, C., & Szabó, R. (2024) · Biomedicines · doi:10.3390/biomedicines12030560 · Cited by 43
Silva, M. S. B., Decoster, L., Delpouve, G., Lhomme, T., Ternier, G., Prévot, V., & Giacobini, P. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104850 · Cited by 41
How polycystic ovary syndrome came into its own
Azziz, R. (2021) · F&S Science · doi:10.1016/j.xfss.2020.12.007 · Cited by 34
Self-citationKiconco, S., Teede, H. J., Azziz, R., Norman, R. J., & Joham, A. E. (2021) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1735259 · Cited by 33
Self-citationSharma, A., Sarwal, Y., Devi, N. K., & Saraswathy, K. N. (2025) · Reproductive Health · doi:10.1186/s12978-025-02019-9 · Cited by 32
Schoretsanitis, G., Gastaldon, C., Kalaitzopoulos, D. R., Ochsenbein‐Kölble, N., Barbui, C., & Seifritz, E. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.044 · Cited by 31
Prevalence of Hirsutism Among Reproductive—Aged African American Women
Chin, H. B., Marsh, E. E., Hall, J. E., & Baird, D. D. (2021) · Journal of Women s Health · doi:10.1089/jwh.2021.0125 · Cited by 28
Kiconco, S., Mousa, A., Azziz, R., Enticott, J., Сутурина, Л. В., Zhao, X., Gambineri, A., Tehrani, F. R., Yıldız, B. O., Kim, J., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11111953 · Cited by 28
Self-citationMaffazioli, G. D. N., Baracat, E. C., Soares, J. M., Carvalho, K. C., & Maciel, G. A. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275031 · Cited by 26
Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndrome
Lempesis, I. G., Apple, S. J., Duarte, G., Palaiodimos, L., Kalaitzopoulos, D. R., Dalamaga, Μ., & Kokkinidis, D. G. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3682 · Cited by 25
Demis, A., Joham, A. E., Tay, C. T., Kiconco, S., Earnest, A., Dhungana, R. R., Сутурина, Л. В., Zhao, X., Gambineri, A., Tehrani, F. R., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf030 · Cited by 25
Self-citationOwens, L. A., & Franks, S. (2025) · Reproduction · doi:10.1530/rep-24-0485 · Cited by 24
Oliveira, F. R., Mamede, M. H., Bizzi, M. F., Rocha, A. L. L., Ferreira, C. N., Gomes, K. B., Cândido, A. L., & dos Reis, F. M. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1157-0615 · Cited by 24
Chen, X., Wan, Y., & Xie, L. (2025) · Biology of Reproduction · doi:10.1093/biolre/ioaf197 · Cited by 23
Özay, A. C., Özay, Ö. E., & Gülekli, B. (2020) · Ginekologia Polska · doi:10.5603/gp.a2020.0122 · Cited by 23
Joham, A. E., Rees, A., Shinkai, K., Forslund, M., Tay, C. T., & Teede, H. J. (2025) · Reproduction · doi:10.1530/rep-25-0121 · Cited by 21
Self-citationWu, P., Zhang, X., Zhou, P., Zhang, W., Li, D., Lv, M., & Liao, X. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.644101 · Cited by 21
Сутурина, Л. В., Lizneva, D., Лазарева, Л. М., Николаевна, Д. И., Nadeliaeva, I. G., Belenkaya, L., Atalyan, A. V., Владимирович, Б. А., Bairova, T. A., Sholokhov, L. F., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae424 · Cited by 20
Self-citationPopulation-Based vs Health System and Insurer Records: Significant Underdiagnosis of PCOS
Hatoum, S., Amiri, M., Hopkins, D., Buyalos, R. P., Bril, F., & Azziz, R. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf037 · Cited by 19
Self-citationKiconco, S., Earnest, A., Enticott, J., Hart, R. J., Mori, T. A., Hickey, M., Teede, H. J., & Joham, A. E. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad055 · Cited by 19
Self-citationEspinosa, M. E., Sánchez, R., Otzen, T., Bautista-Valarezo, E., Aguiar, S., Corrales-Gutiérrez, I., León-Larios, F., & Manterola, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082376 · Cited by 19
Gezer, E., Piro, B., Cantürk, Z., Çetinarslan, B., Sözen, M., Selek, A., IŞIK, A. Ö. P., & Seal, L. (2021) · Transgender Health · doi:10.1089/trgh.2021.0061 · Cited by 17
Eyüpoğlu, D., Aksun, S., Öztürk, M., & Yıldız, B. O. (2022) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-022-01369-8 · Cited by 16
Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19
Ilias, Ι., Goulas, S., & Zabulienė, L. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i12.2711 · Cited by 16
Kim, C., Schreiner, P. J., Siscovick, D. S., Wang, A., Wellons, M., Ebong, I., Vu, T. T., Appiah, D., Catov, J. M., Schisterman, E. F., et al. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02394-0 · Cited by 15
Al Wattar, B. H., Bueno, A., Martin, M. G., Ibáñez, N. C., Harasani, K., Garad, R., Franks, S., Balen, A., Bhide, P., Piltonen, T., et al. (2021) · Human Reproduction · doi:10.1093/humrep/deaa331 · Cited by 14
“Caring for women with polycystic ovary syndrome (PCOS) has progressed over the last few decades thanks to an increasing, still shy, investment in clinical research and evidence-based medicine (Azziz et al., 2019).”
BackgroundSelf-citationMenstrual cycle length and adverse pregnancy outcomes among women in Project Viva
Soria‐Contreras, D. C., Perng, W., Rifas‐Shiman, S. L., Hivert, M., Chavarro, J. E., & Oken, E. (2022) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12866 · Cited by 14
Ma, Y., Cai, J., Liu, L., Wen, T., Huang, W., Hou, W., Wei, Z., Xu, Y., Xu, Y., Wang, Y., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1327849 · Cited by 13
Li, W., Bai, E., & Wang, Q. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1400880 · Cited by 13
Jin, C., Zou, K., Xu, Y., Yang, H., & Pan, J. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00886-4 · Cited by 13
Wattar, B. H. A., Teh, J. J., Clarke, S. A., Abbara, A., Morman, R., Wilcox, A., & Talaulikar, V. S. (2024) · Clinical Endocrinology · doi:10.1111/cen.15038 · Cited by 10
Demis, A., Kiconco, S., Earnest, A., Khomami, M. B., Dhungana, R. R., Azziz, R., Сутурина, Л. В., Zhao, X., Gambineri, A., Tehrani, F. R., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04221-9 · Cited by 10
Self-citation3 CpG Methylation Biomarkers for the Diagnosis of Polycystic Ovary Syndrome (PCOS) in Blood Samples
Zeng, L., Lu, R., Xie, L., Jiang, X., Chen, Y., Huang, C., Chen, Y., Liu, G., & Sun, W.-X. (2021) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207321666210602170054 · Cited by 10
Сутурина, Л. В., Lizneva, D., Atalyan, A. V., Лазарева, Л. М., Владимирович, Б. А., Bairova, T. A., Sholokhov, L. F., Рашидова, М. А., Николаевна, Д. И., Nadeliaeva, I. G., et al. (2022) · Diagnostics · doi:10.3390/diagnostics13010033 · Cited by 10
Self-citationA Review on Acupuncture Efficiency in Human Polycystic Ovary/Ovarian Syndrome
de Oliveira, N. M., Machado, J. P., Lopes, L. T., & Criado, M. B. (2023) · Journal of pharmacopuncture · doi:10.3831/kpi.2023.26.2.105 · Cited by 8
Ganie, M. A., Rashid, A., Baba, M. S., Zargar, M. A., Wani, I. A., Nisar, S., Wani, I. A., Douhath, S., Sriwastawa, M., Geer, M. I., et al. (2023) · Clinical Endocrinology · doi:10.1111/cen.14964 · Cited by 7
Xuan, F., Ren, Y., Lu, J., Zhou, W., Jin, R., Chen, A., & Ye, Y. (2024) · Molecular Reproduction and Development · doi:10.1002/mrd.23741 · Cited by 7
Wang, J., Li, L., Zhou, J., Pan, X., Qi, Q., Sun, H., & Wang, L. (2024) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2024.01003 · Cited by 7
Pace, L. A., Kummer, N., Wallace, M., & Azziz, R. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01702-9 · Cited by 7
Self-citationPolycystic ovary syndrome and organochlorine pesticides: exploring potential links and mechanisms
Yin, S., Yang, W., Lin, F., Jia, M., Feng, Y., Chen, Y., Bai, X., Dong, Y., Mao, S., Hayat, K., et al. (2025) · Frontiers in Reproductive Health · doi:10.3389/frph.2025.1563414 · Cited by 7
The PCOS puzzle: putting the pieces together for optimal care
Dar, M. A., Maqbool, M., & Ara, I. (2023) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2023-0102 · Cited by 7
Oğuz, S. H., Boyraz, B. S., Ertürk, B., & Yıldız, B. O. (2023) · Endocrine · doi:10.1007/s12020-023-03648-5 · Cited by 7
Targeting metabolism in the management of PCOS: Metformin and beyond
Oğuz, S. H., Şendur, S. N., Ünlütürk, U., & Yıldız, B. O. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00006-7 · Cited by 6
Uptake of the core outcome set on polycystic ovary syndrome before and after its publication
Li, W., Li, G., Chi, H., Wang, H., & Zeng, L. (2023) · Human Reproduction · doi:10.1093/humrep/dead149 · Cited by 6
Utomo, H. C., Yuad, H., & Burhan, I. R. (2024) · Andalas obstetrics and gynecology journal · doi:10.25077/aoj.8.1.615-631.2024 · Cited by 6
Role of complementary and alternative medicine in polycystic ovary syndrome
Siddique, R., & Mehmood, M. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00031-1 · Cited by 6
Hypertension and dyslipidemia in women with PCOS: a population-based multiregister study in Sweden
Persson, S., Türkmen, Ş., Hirschberg, A. L., Poromaa, I. S., & Elenis, E. (2026) · Human Reproduction · doi:10.1093/humrep/deag064 · Cited by 5
Wang, W., Hao, J. C., & Shi, Y. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2123914 · Cited by 5
de Oliveira, N. M., Machado, J. P., Huang, Z., & Criado, M. B. (2022) · Healthcare · doi:10.3390/healthcare10101999 · Cited by 5
Сутурина, Л. В., Владимирович, Б. А., Sholokhov, L. F., Рашидова, М. А., Николаевна, Д. И., Лазарева, Л. М., Nadeliaeva, I. G., Belenkaia, L. V., Atalyan, A. V., Vilson, N. I., et al. (2022) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2022-7.6.9 · Cited by 5
Татарчук, Т. Ф., Педаченко, Н. Ю., Косей, Н. В., Malysheva, I., Snizhko, T. B., Козуб, Т., Zolotarevska, O., Kosianenko, S., & Tutchenko, T. М. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.02.011 · Cited by 5
Pace, L. A., Waldeck, J., Chan, J. L., Pisarska, M. D., & Azziz, R. (2024) · Journal of Women s Health · doi:10.1089/jwh.2024.0186 · Cited by 5
Self-citationA Comprehensive PCOS Research and Guideline Translation Program to Improve Practice
Ramasamy, V. A., Garad, R. M., & Boyle, J. A. (2021) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1733916 · Cited by 5
Wu, P., Li, R. Z., Zhang, W., Su, Z. Z., & Lin, Y. H. (2021) · Biomedical and Environmental Sciences · doi:10.3967/bes2021.023 · Cited by 5
Self-citationThe Epidemiology of Polycystic Ovary Syndrome
Suturina, L. (2022) · Polycystic Ovary Syndrome · doi:10.1017/9781108989831.003 · Cited by 4
Cebada, A. B., Nattero‐Chávez, L., de la Villa, E. D. L. C., Tobar, A. Q., Quiñones, S. D. L., Avendaño, B. D., Fiers, T., Jean-Marc, K., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2025) · Human Reproduction Open · doi:10.1093/hropen/hoaf048 · Cited by 4
Tay, C. T., Joham, A. E., Moran, L., & Teede, H. J. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000770 · Cited by 4
Self-citationChen, H., & Liang, X. (2024) · Pharmacognosy Magazine · doi:10.1177/09731296241234124 · Cited by 4
Disparities in the Diagnosis and Management of Polycystic Ovarian Syndrome in Adolescents
Waldrop, S., Buenaventura, M., Reyes, K. J. C., & Stanford, F. C. (2025) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2025.02.016 · Cited by 4
Krasnopolskaya, K. V., Sokolova, E. A., Ershova, I. Y., & Isakova, K. M. (2020) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20202004188 · Cited by 4
Cheng, R., Zhu, Y., Yang, L., Lu, X. J., Fang, X., & Zhang, Q. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2463533 · Cited by 3
Lifestyle in Polycystic Ovary Syndrome
Garad, R. M., Lim, S. S., & Moran, L. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108989831.010 · Cited by 3
Лазарева, Л. М. (2023) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2023-8.4.7 · Cited by 3
Endometrial condition in patients with polycystic ovary syndrome
Sokolova, E. A., Krasnopolskaya, K. V., Belokurova, M. V., & Isakova, K. M. (2021) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20212102186 · Cited by 3
Metabolic health outcomes among women with polycystic ovary syndrome
Kumarendran, B. (2024) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 3
Increased Serum Levels of LDHA and TPI1 in Patients With Polycystic Ovary Syndrome
Wang, W., Yan, T., Sun, M., Li, Y., & Lou, J. (2025) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.70032 · Cited by 2
Sodero, G., Cipolla, C., Arzilli, F., & Rendeli, C. (2025) · Children · doi:10.3390/children12070851 · Cited by 2
Sajid, N., Kiran, A., Iftikhar, A., & Bashir, K. (2024) · The Journal of Basic and Applied Zoology · doi:10.1186/s41936-024-00385-7 · Cited by 2
Avaliação do perfil de miRNAs circulantes em pacientes com síndrome dos ovários policísticos
Maffazioli, G. D. N. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-16082021-130548 · Cited by 2
Aziz, N. A. A., Budin, S. B., Yussof, M. A. M., Rajab, N. F., & Taib, I. S. (2024) · Malaysian Journal of Medicine and Health Sciences · doi:10.47836/mjmhs.20.4.36 · Cited by 1
de Souza, A. T. B., Torres, K. L. D. S., Sarmento, A. C. A., de Lima, A. S. B., de Medeiros, K. S., Dantas, D. D. S., Cobucci, R. N., Gonçalves, A. K., & Crispim, J. C. D. O. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70255 · Cited by 1
Jafarzadeh, E., Pashaei‐Asl, R., Hakimi, P., & Pashaiasl, M. (2025) · Journal of Reproduction & Infertility · doi:10.18502/jri.v26i2.19433 · Cited by 1
Lin, S., Qi, S.-Y., Ma, D.-T., Yang, J., Chen, X.-L., Lin, T., Gao, H.-H., Chen, H.-Y., Yu-nan, H., Lin, J., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1705096 · Cited by 1
Tijare, D. C., Arya, S., Loharkar, S., Jindal, A., Veerabomma, H., Dighe, V., Katyal, A., Chandra, R., & Madan, J. (2026) · BioNanoScience · doi:10.1007/s12668-026-02722-2 · Cited by 1
Beyond the Surface: The Hidden Struggles of PCOS
Malik, A. B., Qadrie, Z., & Dar, M. A. (2023) · International Journal of Current Research in Physiology and Pharmacology (IJCRPP) · Cited by 1
Salama, K. M., Sakr, B., & Azab, S. A. (2021) · Benha Journal of Applied Sciences · doi:10.21608/bjas.2021.169459 · Cited by 1
Significance of Serum Relaxin in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease
Elashmoney, E. A., El-Gharbawy, N. M., Hodeib, H., & Al-Naggar, M. M. (2022) · Journal of Advances in Medicine and Medical Research · doi:10.9734/jammr/2022/v34i1831426 · Cited by 1
Zheng, X., Zhou, C., Xu, W., Jia, J.-J., Li, B., Lv, G., & Chen, S. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2368845 · Cited by 1
Comim, F. V. (2020) · Clinical Endocrinology · doi:10.1111/cen.14171 · Cited by 1
de Oliveira, N. M. G. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/cv16-6m70 · Cited by 1
Boots, C. E., & Goldberg, A. S. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.10.031 · Cited by 1
Yan, X., Ding, R., Liu, Y., Guo, Y., & Wang, L. (2022) · Research Square · doi:10.21203/rs.3.rs-1719091/v1
Androgenisierung: Diagnostik und Therapie – Akne vulgaris, Hirsutismus, female pattern hair loss
Geisthövel, F., Wetzka, B., & Hanjalic-Beck, A. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-47329-0_17-1
Recombinant follitropins in IVF programs in patients with polycystic ovary syndrome
Krasnopolskaya, K. V., Ershova, I. Y., Isakova, K. M., Samoilova, A. A., Garina, A. O., & Shostenko, L. V. (2023) · Russian Journal of Human Reproduction · doi:10.17116/repro20232901148
Dessinioti, C., & Katsambas, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-15130-9_40
Nonhemodynamic Components of EVA: Polycystic Ovary Syndrome (PCOS)
Lambrinoudaki, I. V., & Armeni, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15512-3.00004-0
Endocrine and Metabolic Effects on Maternal-fetal and Neonatal Outcomes, Volume II
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5459-3
Falh, Z. G., Saleh, B. O. M., Al-Naddawi, A. M., & Mohammed, G. (2024) · Journal of the Faculty of Medicine Baghdad · doi:10.32007/jfacmedbaghdad.6642418
Metadata
- Authors
- Azziz, R., Kintziger, K., Li, R., Laven, J., Morin-Papunen, L., Merkin, S. S., Teede, H., & Yildiz, B. O.
- Affiliations
- State University of New York (US)
- University of Tennessee at Knoxville (US)
- Peking University Third Hospital (CN)
- Erasmus MC (NL)
- Oulu University Hospital (FI)
- University of California, Los Angeles (US)
- Monash University (AU)
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Hacettepe University School of Medicine, Hacettepe, Ankara, Turkey
- Corresponding author
- Azziz, Ricardo
- ORCID
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-11-01
- Volume
- 34
- Issue
- 11
- Pages
- 2254-2265
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2990595775
- Cited by
- 108
- References
- 24
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 24 · 2023: 20 · 2022: 14 · 2021: 18 · 2020: 6
- FWCI
- 9.08
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Funders
- Ferring Pharmaceuticals
- Netherlands Organisation for Health Research and Development
- Medical Research Council
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, PCOS phenotypes, study design recommendations, diagnostic criteria, hyperandrogenism, oligoanovulation, polycystic ovary morphology, androgen levels, ovarian ultrasonography, normative ranges
- MeSH terms
- Algorithms, Androgens, Anovulation, Endocrinology, Female, Gynecology, Humans, Longitudinal Studies, Ovary, Phenotype, Polycystic Ovary Syndrome, Quality Control, Research Design, Observer Variation, Treatment Outcome, Guidelines as Topic, Hyperandrogenism, Biological Specimen Banks, Biomedical Research, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.